Another record-breaking quarter in the books. Here’s a look at the top startup fundings. Everything you need to need to know about the largest NYC startup funding rounds of Q2 2021; broken down by industry, stage, investors, and more…
While the growth of big data and analytics help businesses understand their customers, serve better ads, and sell more, in healthcare, these same methodologies and technologies have a real enduring, profound societal impact. Real-world data (RW) and real-world evidence (RWE), made possible by technology, are being used by pharmaceutical companies and the healthcare ecosystem to develop, evaluate, implement, and optimize new treatment approaches. Aetion is the RWD and RWE platform that enables the healthcare system to harness the power of data to shape the future of medicine. The platform is designed to accelerate the time to market without compromising scientific rigor. For example, the company partnered with the FDA to develop real-world analytics related to COVID and vaccines. AlleyWatch caught up with CEO Carolyn Magill to learn more about Aetion’s approach to RWD is enabling the healthcare system to make informed decisions, the company’s strategic, plans, latest round of funding, and much, much more.
The Weekly Notable Startup Funding Report takes us on a trip across various ecosystems in the US, highlighting some of the notable funding activity in the various markets that we track. The notable startup funding rounds for the week ending 5/15/21 featuring funding details for Ethos, Handshake, SightCall, and twenty-eight other rounds that you must know about.
Over $180M in funding raised! The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 5/11/2021 featuring funding details for Windmill, Sanctuary, and much more.
Clinical data has the potential to transform the healthcare system and we are in the midst of a healthcare data revolution. However, health care data can be unique and difficult to measure. Aetion, the Real World Evidence Platform®, allows the healthcare industry to make critical decisions about treatments and drug development from a high-level and detailed perspective. Real World Evidence leads to informed decision-making and Aetion, founded by two physicians from Harvard, enables this with a focus on technology and big data. CEO Carolyn Magill shares more about how the company powers regulators, biopharma, payers, and health technology assessment (HTA) bodies, the company’s future plans, and Aetion’s Series B, which brings the total round size to $82B extension. Aetion has now raised a total of $93.6M across five rounds.
NYC Tech News for the week ending 8/29 including news for Dataiku, Ocrolus, Wrapbook, and much more…
The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 8/26/2020 featuring funding details for Aetion, Esusu Financial, and much more.
Armed with some data from our friends at CrunchBase, I broke down the 14 largest NYC Startup funding rounds in New York during the month of February 2019. I have included some additional information such as industry, description, round type, total equity funding raised, funding details, and links to AlleyWatch full coverage to further the analysis for the state of venture […]
NYC Tech News for the week ending 2/9 including the NYC startup fundings, NYC startup exits, and NYC Tech events including news for Aetion, Rebag, Little Spoon, and much more…
Most people have read about an exciting, “breakthrough” in medicine and only to discover a couple paragraphs later that the results are based upon a sample size of 30 people, but Aetion uses real-world data from sources that include insurance claims, electronic medical records, and patient-reported outcomes to enable healthcare organizations to make impactful, informed […]